نتایج جستجو برای: escitalopram

تعداد نتایج: 1125  

Journal: :International clinical psychopharmacology 2013
Rafael Stryjer Yael Dambinsky Igor Timinsky Tamar Green Moshe Kotler Abraham Weizman Baruch Spivak

The current data suggest that up to 50% of patients with schizophrenia have obsessive-compulsive (OC) symptoms coexisting with psychosis and between 7.8 and 46% of schizophrenia patients also have full-blown obsessive-compulsive disorder (OCD). The aim of this study was to examine the efficacy of the most selective serotonin reuptake inhibitor escitalopram in the management of OCD in schizophre...

2014
K. Mihara S. Kagawa T. Suzuki T. Kondo

▼ Introduction: The eff ects of escitalopram (10 mg/d) coadministration on plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, were studied in 13 Japanese psychiatric patients and compared with those of paroxetine (10 mg/d) coadministration. Methods: The patients had received 6–24 mg/d of aripiprazole for at least 2 weeks. Patients were randomly allocated to on...

2009
Andrew Farah

What are the therapeutic advantages of escitalopram, the purified S-enantiomer of the racemate citalopram? The biological activity and therapeutic effects of citalopram, which has been used for over a decade to effectively treat depression and other psychiatric disorders, have been shown to reside exclusively in escitalopram. Escitalopram has been shown in vitro to be more than twice as potent ...

Journal: :JAMA 2011
Ellen W Freeman Katherine A Guthrie Bette Caan Barbara Sternfeld Lee S Cohen Hadine Joffe Janet S Carpenter Garnet L Anderson Joseph C Larson Kristine E Ensrud Susan D Reed Katherine M Newton Sheryl Sherman Mary D Sammel Andrea Z LaCroix

CONTEXT Concerns regarding the risks associated with estrogen and progesterone to manage menopausal symptoms have resulted in its declining use and increased interest in nonhormonal treatments with demonstrated efficacy for hot flashes. OBJECTIVE To determine the efficacy and tolerability of 10 to 20 mg/d escitalopram, a selective serotonin reuptake inhibitor, in alleviating the frequency, se...

2011
Mazen K Ali Raymond W Lam

BACKGROUND Escitalopram is an allosteric selective serotonin reuptake inhibitor (SSRI) with some indication of superior efficacy in the treatment of major depressive disorder. In this systematic review, we critically evaluate the evidence for comparative efficacy and tolerability of escitalopram, focusing on pooled and meta-analysis studies. METHODS A literature search was conducted for escit...

Journal: :Managed care 2012
Eric Q Wu Rym Ben-Hamadi Mei Lu Nicolas Beaulieu Andrew P Yu M Haim Erder

OBJECTIVE Compare treatment persistence and health care costs of major depressive disorder (MDD) Medicaid patients treated with escitalopram versus citalopram. DESIGN Retrospective analysis of Medicaid administrative claims data. METHODOLOGY Analyzed administrative claims data from the Florida Medicaid program (07/2002-06/2006) for patients ages 18-64 years with 21 inpatient claim or 2 inde...

Journal: :Anesthesiology 2015
Troels H Lunn Vibe G Frokjaer Torben B Hansen Per W Kristensen Thomas Lind Henrik Kehlet

BACKGROUND Sufficient pain treatment remains a challenge after total knee arthroplasty (TKA), especially in high pain catastrophizing patients. Serotonergic signaling may be involved in pain processing, but the effect of selective serotonin reuptake inhibitors on well-defined postoperative pain has not previously been investigated. The authors hypothesized that perioperative escitalopram would ...

2012
Ulla Knorr Maj Vinberg Erik Lykke Mortensen Per Winkel Christian Gluud Jørn Wetterslev Ulrik Gether Lars Vedel Kessing

INTRODUCTION The serotonergic neurotransmitter system is closely linked to depression and personality traits. It is not known if selective serotonin reuptake inhibitors (SSRI) have an effect on neuroticism that is independent of their effect on depression. Healthy individuals with a genetic liability for depression represent a group of particular interest when investigating if intervention with...

Journal: :Journal of psychiatry & neuroscience : JPN 2009
Eliyahu Dremencov Mostafa El Mansari Pierre Blier

BACKGROUND Selective serotonin (5-HT) reuptake inhibitors (SSRIs) are efficacious in depression because of their ability to increase 5-HT neurotransmission. However, owing to a purported inhibitory effect of 5-HT on dopamine (DA) neuronal activity in the ventral tegmental area (VTA), this increase in 5-HT transmission might result in a suppression of the firing activity of DA neurons. Since the...

Journal: :Journal of chromatographic science 2013
Rajendra B Kakde Dinesh D Satone Kamalesh K Gadapayale Megha G Kakde

The objective of the current study was to develop a validated, specific stability-indicating reversed-phase liquid chromatographic (LC) method for the quantitative determination of escitalopram oxalate and clonazepam and their related substances in bulk drugs and pharmaceutical dosage forms in the presence of degradation products. Forced degradation studies were performed on the pure drugs of e...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید